NCT04460456 2022-06-30A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsSilverback TherapeuticsPhase 1 Unknown58 enrolled
NCT04107142 2019-09-27Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourCytoMed Therapeutics Pte LtdPhase 1 Unknown10 enrolled
NCT03076372 2018-02-27A Study Evaluating MM-310 in Patients With Solid TumorsMerrimack PharmaceuticalsPhase 1 Unknown34 enrolled